ask="1.140"
ask_size="600"
average_daily_volume="108558"
bid="0.670"
bid_size="800"
book_value="0.531"
change="+0.002"
change_from_200_day_moving_average="-0.464"
change_from_50_day_moving_average="-0.245"
change_from_52_week_high="-6.985"
change_From_52_week_low="0.045"
change_in_percent="+0.223%"
close="0.965"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.010"
ebitda="-15.83M"
eps_estimate_current_year="-0.820"
eps_estimate_next_quarter="-0.220"
eps_estimate_next_year="-0.730"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.000"
high_52_weeks="7.950"
last_trade_date="3/3/2017"
last_trade_price="0.965"
last_trade_size="300"
last_trade_time="3:56pm"
low="0.940"
low_52_weeks="0.920"
market_capitalization="15.82M"
moving_average_200_day="1.429"
moving_average_50_day="1.210"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.000"
open="0.945"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-32.477%"
percent_change_from_50_day_moving_average="-20.254%"
percent_change_from_52_week_high="-87.862%"
percent_change_from_52_week_low="+4.869%"
previous_close="0.963"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.813"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.590"
stock_exchange="NGM"
symbol="ORPN"
volume="72243"
weeks_range_52="0.920 - 7.950"
